Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Can-Fite BioPharma Ltd.

    AMEX: CANF · Real-Time Price · USD
    1.14
    0.07 (6.54%)
    At close: Jun 16, 2025, 11:08 AM

    Can-Fite BioPharma Statistics

    Share Statistics

    Can-Fite BioPharma has 12.88M shares outstanding. The number of shares has increased by -2.29% in one year.

    Shares Outstanding

    n/a
    		 12.88M

    Shares Change (YoY)

    n/a
    		 -2.29%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 1.58%

    Shares Floating

    n/a
    		 10.35M

    Failed to Deliver (FTD) Shares

    n/a
    		 381

    FTD / Avg. Volume

    n/a
    		 0.13%

    Short Selling Information

    The latest short interest is 77.47K, so 0.6% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 77.47K

    Short % of Shares Out

    n/a
    		 0.6%

    Short % of Float

    n/a
    		 0.6%

    Short Ratio (days to cover)

    n/a
    		 1.39

    Valuation Ratios

    The PE ratio is -1.5 and the forward PE ratio is -35.83. Can-Fite BioPharma's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -1.5

    Forward PE

    n/a
    		 -35.83

    PS Ratio

    n/a
    		 17.54

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 2.18

    P/FCF Ratio

    n/a
    		 -1.55

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Can-Fite BioPharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.38, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 4.38

    Quick Ratio

    n/a
    		 4.38

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -580.71

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $134,800

    Profits Per Employee

    n/a
    		 $-1,576,000

    Employee Count

    n/a
    		 5

    Asset Turnover

    n/a
    		 0.07

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -68.66% in the last 52 weeks. The beta is 0.23, so Can-Fite BioPharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.23

    52-Week Price Change

    n/a
    		 -68.66%

    50-Day Moving Average

    n/a
    		 1.16

    200-Day Moving Average

    n/a
    		 1.7

    Relative Strength Index (RSI)

    n/a
    		 42.48

    Average Volume (20 Days)

    n/a
    		 282,714

    Income Statement

    In the last 12 months, Can-Fite BioPharma had revenue of 674K and earned -7.88M in profits. Earnings per share was -1.08.

    Revenue

    n/a
    		 674K

    Gross Profit

    n/a
    		 674K

    Operating Income

    n/a
    		 -8.13M

    Net Income

    n/a
    		 -7.88M

    EBITDA

    n/a
    		 -8.12M

    EBIT

    n/a
    		 -8.13M

    Earnings Per Share (EPS)

    n/a
    		 -1.08
    Full Income Statement

    Balance Sheet

    The company has 4.83M in cash and 104K in debt, giving a net cash position of 4.72M.

    Cash & Cash Equivalents

    n/a
    		 4.83M

    Total Debt

    n/a
    		 104K

    Net Cash

    n/a
    		 4.72M

    Retained Earnings

    n/a
    		 -166.36M

    Total Assets

    n/a
    		 9.12M

    Working Capital

    n/a
    		 6.93M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -7.64M and capital expenditures -5K, giving a free cash flow of -7.64M.

    Operating Cash Flow

    n/a
    		 -7.64M

    Capital Expenditures

    n/a
    		 -5K

    Free Cash Flow

    n/a
    		 -7.64M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -1206.23% and -1169.14%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -1206.23%

    Pretax Margin

    n/a
    		 -1169.14%

    Profit Margin

    n/a
    		 -1169.14%

    EBITDA Margin

    n/a
    		 -1205.19%

    EBIT Margin

    n/a
    		 -1206.23%

    FCF Margin

    n/a
    		 -1133.83%

    Dividends & Yields

    CANF does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CANF is $10, which is 852.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 852.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 9, 2023. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jan 9, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -27.49

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist